Mark Cuban has a straightforward question for the drug middleman owned by CVS: If you're as transparent about drug pricing as you claim, why don't you publish prices on your website?
The maker of Tylenol, Listerine, Neutrogena, Band-Aids and Benadryl plans a global headquarters in New Jersey with over 3,000 scientists and other employees over the next few years.
The New Jersey-based drugmaker said it expected annual earnings of $8.53 to $8.65 per share, up from its previous forecast of $8.44 to $8.59. Analysts had estimated earnings of $8.56 per share.
Walgreens will start working directly with drugmakers to bring cell and gene therapies to U.S. patients as part of a broader effort to expand its specialty pharmacy services.
DOJ is conducting a criminal investigation into consulting firm McKinsey related to its past role in advising some of the nation's largest opioid makers on how to boost sales.